Literature DB >> 11600503

Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum.

J Fey1, M Balleininger, L V Borissenko, B Schmidt, K von Figura, T Dierks.   

Abstract

C(alpha)-formylglycine is the key catalytic residue in the active site of sulfatases. In eukaryotes formylglycine is generated during or immediately after sulfatase translocation into the endoplasmic reticulum by oxidation of a specific cysteine residue. We established an in vitro assay that allowed us to measure formylglycine modification independent of protein translocation. The modifying enzyme was recovered in a microsomal detergent extract. As a substrate we used ribosome-associated nascent chain complexes comprising in vitro synthesized sulfatase fragments that were released from the ribosomes by puromycin. Formylglycine modification was highly efficient and did not require a signal sequence in the substrate polypeptide. Ribosome association helped to maintain the modification competence of nascent chains but only after their release efficient modification occurred. The modifying machinery consists of soluble components of the endoplasmic reticulum lumen, as shown by differential extraction of microsomes. The in vitro assay can be performed under kinetically controlled conditions. The activation energy for formylglycine formation is 61 kJ/mol, and the pH optimum is approximately 10. The activity is sensitive to the SH/SS equilibrium and is stimulated by Ca(2+). Formylglycine formation is efficiently inhibited by a synthetic sulfatase peptide representing the sequence directing formylglycine modification. The established assay system should make possible the biochemical identification of the modifying enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600503     DOI: 10.1074/jbc.M108943200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.

Authors:  Dirk Roeser; Andrea Preusser-Kunze; Bernhard Schmidt; Kathrin Gasow; Julia G Wittmann; Thomas Dierks; Kurt von Figura; Markus Georg Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-20       Impact factor: 11.205

2.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

3.  Proprotein convertases process and thereby inactivate formylglycine-generating enzyme.

Authors:  Eva C Ennemann; Karthikeyan Radhakrishnan; Malaiyalam Mariappan; Michaela Wachs; Thomas H Pringle; Bernhard Schmidt; Thomas Dierks
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

Review 4.  Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications.

Authors:  Mason J Appel; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

5.  Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.

Authors:  Sumit Bhattacharyya; Joanne K Tobacman
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.